Keep this leaflet with the medicine. You may need to read it again. TRELEGY ELLIPTA is a dry powder inhaler. When you breathe in using the inhaler, the medicine is deposited into the lungs.

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

Relvar Ellipta is a once-daily dual combination treatment comprising fluticasone furoate, an inhaled corticosteroid and vilanterol, a long-acting beta2-agonist, in a single inhaler, the Ellipta.

FF/VI was administered once daily via the Ellipta inhaler. Patients who were taking a LAMA in addition to ICS/LABA therapy (triple therapy) who were randomised to the FF/VI group were able to ...

Doctors could be taught to limit the use of traditional asthma inhalers due to their environmental impact. This initiative, led by the University of Glasgow and coordinated by the European ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...